Toll-like receptor (tlrs) agonists and antagonists for covid-19 treatments

HIGHLIGHTS

• who: . and collaborators from the Kazi Nazrul University, India have published the paper: Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments, in the Journal: (JOURNAL)
• what: This study has implications for the COVID19treatment and prevention: applying TLR2 antagonists such as oxPAPC in patients with outbreaks of excessive inflammation may reduce the inflammatory response and possibly improve the cure rates of patients (Zheng et_al, 2021).
• how: In the review the SARS-CoV-2 invasion and pathogenic molecular mechanisms the roles of different TLRs in SARS-CoV-2 infection and whether agonists . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.